Plasmacytoid dendritic cells in atherosclerosis

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Döring, Yvonne ^a   Zernecke, Alma ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Plasmacytoid dendritic cells; Type I IFN

Indexed keywords

EID: 84866379222     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00230     Document Type: Article

References (126)

1. Ait-Oufella, H., Salomon, B. L., Pot-teaux, S., Robertson, A. K., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., Flavell, R. A., Hansson, G. K., Klatzmann, D., Tedgui, A., and Mallat, Z. (2006). Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180.
2. Aprahamian, T., Rifkin, I., Bonegio, R., Hugel, B., Freyssinet, J. M., Sato, K., Castellot, J. J. Jr., and Walsh, K.(2004).Impairedclearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199, 1121-1131.
3. Arbuckle, M. R., Mcclain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., and Harley, J. B. (2003). Development of autoantibodies before the clinical onset of systemic lupus erythe-matosus. N. Engl. J. Med. 349, 1526-1533.
4. Asselin-Paturel, C., Brizard, G., Pin, J. J., Briere, F., and Trinchieri, G. (2003). Mouse strain differences in plasma-cytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171, 6466-6477.
5. Banchereau, J., and Pascual, V. (2006). Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25, 383-392.
6. Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., and Coff-man, R. L. (2005). Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202, 1131-1139.
7. Barton, G. M., Kagan, J. C., and Medzhitov, R. (2006). Intracellu-lar localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7, 49-56.
8. Binder, C. J., Hartvigsen, K., Chang, M. K., Miller, M., Broide, D., Palin-ski, W., Curtiss, L. K., Corr, M., and Witztum, J. L. (2004). IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114, 427-437.
9. Blanco, P., Palucka, A. K., Gill, M., Pas-cual, V., and Banchereau, J. (2001). Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294, 1540-1543.
10. Blasi, C. (2008). The autoimmune origin of atherosclerosis. Atherosclerosis 201, 17-32.
11. Blasius, A. L., Cella, M., Maldonado, J., Takai, T., and Colonna, M. (2006a). Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107, 2474-2476.
12. Blasius, A. L., Giurisato, E., Cella, M., Schreiber, R. D., Shaw, A. S., and Colonna, M. (2006b). Bone marrow stromal cell antigen 2 is a specific markerof typeIIFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177, 3260-3265.
13. Blomberg, S., Eloranta, M. L., Cederblad, B., Nordlin, K., Alm, G. V., and Ronnblom, L. (2001). Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus 10, 484-490.
14. Bobryshev, Y. V. (2010). Dendritic cells and their role in atherogenesis. Lab. Invest. 90, 970-984.
15. Bobryshev, Y. V., and Lord, R. S. (1995). Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta. Arch. Histol. Cytol. 58, 307-322.
16. Braunersreuther, V., Zernecke, A., Arnaud, C., Liehn, E. A., Steffens, S., Shagdarsuren, E., Bidzhekov, K., Burger, F., Pelli, G., Luckow, B., Mach, F., and Weber, C. (2007). Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27, 373-379.
17. Choi, J. H., Cheong, C., Dandamudi, D. B., Park, C. G., Rodriguez, A., Mehandru, S., Velinzon, K., Jung, I. H., Yoo, J. Y., Oh, G. T., and Steinman, R. M. (2011). Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 35, 819-831.
18. Choi, J. H., Do, Y., Cheong, C., Koh, H., Boscardin, S. B., Oh, Y. S., Bozzacco, L., Trumpfheller, C., Park, C. G., and Steinman, R. M. (2009). Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206, 497-505.
19. Corrales, J. J., Almeida, M., Burgo, R. M., Hernandez, P., Miralles, J. M., and Orfao,A.(2007).Decreasedpro-duction of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. J. Diabetes Complicat. 21, 41-49.
20. Cybulsky, M. I., and Jongstra-Bilen, J. (2010). Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol. 21, 397-403.
21. Daissormont, I. T., Christ, A., Temmerman, L., Sampedro Millares, S., Seijkens, T., Manca, M., Rousch, M., Poggi, M., Boon, L., van Der Loos, C., Daemen, M., Lutgens, E., Halvorsen, B., Aukrust, P., Janssen, E., and Biessen, E.A. (2011). Plasma-cytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ. Res. 109, 1387-1395.
22. Denny, M. F., Thacker, S., Mehta, H., Somers, E. C., Dodick, T., Barrat, F. J., Mccune, W. J., and Kaplan, M. J. (2007). Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 110, 2907-2915.
23. Döring, Y., Manthey, H., Drechsler, M., Lievens, D., Megens, R., Soehnlein, O., Busch, M., Manca, M., Koenen, R. R., Pelisek, J., Daemen, M. J., Zenke, M., Lutgens, E., Binder, C. J., Weber, C., and Zernecke, A. (2012). Autoantigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 125, 1673-1683.
24. Drechsler, M., Megens, R. T., van Zand-voort, M., Weber, C., and Soehnlein, O. (2010).Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122, 1837-1845.
25. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Gunther, G., Johnston, I., Lanza-vecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G., Yamamoto, T., Zysk, M., Yamaguchi, Y., and Schmitz, J. (2001). BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/betainduction. J. Exp. Med. 194, 1823-1834.
26. Edfeldt, K., Agerberth, B., Rottenberg, M. E., Gudmundsson, G. H., Wang, X. B., Mandal, K., Xu, Q., and Yan, Z. Q. (2006). Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 1551-1557.
27. Eloranta, M. L., Lovgren, T., Finke, D., Mathsson, L., Ronnelid, J., Kastner, B., Alm, G. V., and Ronnblom, L. (2009). Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum. 60, 2418-2427.
28. Facchetti, F., and Vergoni, F. (2000). The plasmacytoid monocyte: from morphology to function. Adv. Clin. Path. 4, 187-190.
29. Fitzgerald-Bocarsly, P., Dai, J., and Singh, S. (2008). Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 19, 3-19.
30. Frostegard, J. (2008). Systemic lupus erythematosus and cardiovascular disease. Lupus 17, 364-367.
31. Fuchs, T. A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D. D. Jr., Wrobleski, S. K., Wakefield, T. W., Hartwig, J. H., and Wagner, D. D. (2010). Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. U.S.A. 107, 15880-15885.
32. Galkina, E., Kadl,A., Sanders, J.,Varugh-ese, D., Sarembock, I. J., and Ley, K. (2006). Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203, 1273-1282.
33. Galkina, E., and Ley, K. (2009). Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27, 165-197.
34. Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., Barrat, F. J., Banchereau, J., and Pascual, V. (2011). Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20.
35. Gautier,E. L., Huby, T., Saint-Charles, F., Ouzilleau, B., Pirault, J., Deswaerte, V., Ginhoux, F., Miller, E. R., Witz-tum, J. L., Chapman, M. J., and Lesnik,P. (2009). Conventional dendritic cells at the crossroads between immunity and cholesterol home-ostasis in atherosclerosis. Circulation 119, 2367-2375.
36. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., and Ley, K. (2010). Development of mono-cytes, macrophages, and dendritic cells. Science 327, 656-661.
37. Gerlini, G., Mariotti, G., Bianchi, B., and Pimpinelli, N. (2006). Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions. J. Invest. Dermatol. 126, 507-509.
38. Ghazizadeh, R., Shimizu, H., Tosa, M., and Ghazizadeh, M. (2010). Pathogenic mechanisms shared between psoriasis and cardiovascular disease. Int. J. Med. Sci. 7, 284-289.
39. Gilliet, M., Cao, W., and Liu,Y. J. (2008). Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606.
40. Goossens, P., Gijbels, M. J., Zernecke, A., Eijgelaar, W., Vergouwe, M. N., van Der Made, I., Vanderlocht, J., Beckers, L., Buurman, W. A., Dae-men, M. J., Kalinke, U., Weber, C., Lutgens, E., and De Winther, M. P. (2010). Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab. 12, 142-153.
41. Gotsman, I., Grabie, N., Gupta, R., Dacosta, R., Macconmara, M., Led-erer, J., Sukhova, G., Witztum, J. L., Sharpe, A. H., and Lichtman, A. H. (2006). Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114, 2047-2055.
42. Grouard, G., Rissoan, M. C., Filgueira, L., Durand, I., Banchereau, J., and Liu,Y. J. (1997). The enigmatic plas-macytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185, 1101-1111.
43. Guiducci, C., Gong, M., Xu, Z., Gill, M.,Chaussabel,D.,Meeker,T.,Chan, J. H., Wright, T., Punaro, M., Bol-land, S., Soumelis, V., Banchereau, J., Coffman, R. L., Pascual, V., and Bar-rat, F. J. (2010). TLR recognition of self nucleic acids hampers glucocor-ticoid activity in lupus. Nature 465, 937-941.
44. Hadeiba, H., Sato, T., Habtezion, A., Oderup, C., Pan, J., and Butcher, E. C. (2008). CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.Nat. Immunol.9, 1253-1260.
45. Hansson, G. K., and Hermansson, A. (2011). The immune system in atherosclerosis. Nat. Immunol. 12, 204-212.
46. Hansson, G. K., Robertson, A. K., and Soderberg-Naucler, C. (2006). Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297-329.
47. Hermansson, A., Johansson, D. K., Ketelhuth, D. F., Andersson, J., Zhou, X., and Hansson, G. K. (2011). Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 123, 1083-1091.
48. Hermansson, A., Ketelhuth, D. F., Strodthoff, D., Wurm, M., Hans-son, E. M., Nicoletti, A., Paulsson-Berne, G., and Hansson, G. K. (2010). Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J. Exp. Med. 207, 1081-1093.
49. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., and Taniguchi, T. (2005). Spa-tiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035-1040.
50. Ito, T., Amakawa, R., Inaba, M., Ike-hara, S., Inaba, K., and Fukuhara, S. (2001). Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166, 2961-2969.
51. Ito, T., Kanzler, H., Duramad, O., Cao, W., and Liu, Y. J. (2006). Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107, 2423-2431.
52. Jego, G., Palucka, A. K., Blanck, J. P., Chalouni, C., Pascual, V., and Banchereau, J. (2003). Plasmacytoid dendritic cells induce plasma cell differentiation through type I inter-feron and interleukin 6. Immunity 19, 225-234.
53. Johnson, B. A. 3rd, Baban, B., and Mellor, A. L. (2009). Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy. Immunotherapy 1, 645-661.
54. Jongstra-Bilen, J., Haidari, M., Zhu, S. N., Chen, M., Guha, D., and Cybul-sky, M. I. (2006). Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073-2083.
55. Ju, X., Clark, G., and Hart, D. N. (2010). Review of human DC subtypes. Methods Mol. Biol. 595, 3-20.
56. Kadowaki, N., Antonenko, S., Lau, J. Y., and Liu, Y. J. (2000). Natural inter-feron alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192, 219-226.
57. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F., and Liu, Y. J. (2001). Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
58. Kessenbrock, K., Krumbholz, M., Schonermarck, U., Back, W., Gross, W. L., Werb, Z., Grone, H. J., Brinkmann, V., and Jenne, D. E. (2009). Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623-625.
59. Kleemann, R., Zadelaar, S., and Koois-tra, T. (2008). Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 79, 360-376.
60. Koltsova,E. K., and Ley, K. (2011). How dendritic cells shape atherosclerosis. Trends Immunol. 32, 540-547.
61. Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J., Andersson, L., Koehn, S., Rhee, J. S., Silverstein, R., Hoff, H. F., and Freeman, M. W. (2002). Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipopro-tein leading to lipid loading in macrophages. J. Biol. Chem. 277, 49982-49988.
62. Lande, R., Gafa, V., Serafini, B., Giaco-mini, E., Visconti, A., Remoli, M. E., Severa, M., Parmentier, M., Ristori, G., Salvetti, M., Aloisi, F., and Coccia, E.M. (2008).Plasmacytoiddendritic cells in multiple sclerosis: intracere-bral recruitment and impaired maturation in response to interferon-beta. J. Neuropathol. Exp. Neurol. 67, 388-401.
63. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., Bassett, R., Amuro, H., Fukuhara, S., Ito, T., Liu, Y. J., and Gilliet, M. (2011). Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide com-plexesinsystemic lupus erythemato-sus. Sci. Transl. Med. 3, 73ra19.
64. Lande, R., and Gilliet, M. (2010). Plas-macytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann. N. Y. Acad. Sci. 1183, 89-103.
65. Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y. H., Homey, B., Cao, W., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schroder, J. M., Liu, Y. J., and Gilliet, M. (2007). Plasma-cytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569.
66. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., and Tough, D. F. (2001). Type i inter-ferons potently enhance humoral immunity and can promote iso-type switching by stimulating dendritic cells in vivo. Immunity 14, 461-470.
67. Lee, P. Y., Li, Y., Richards, H. B., Chan, F. S., Zhuang, H., Narain, S., But-filoski, E. J., Sobel, E. S., Reeves, W. H., and Segal, M. S. (2007). Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 56, 3759-3769.
68. Lennert, K., and Remmele, W. (1958). [Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts & lymphocytes. Acta Haematol. 19, 99-113.
69. Levy, Z., Rachmani, R., Trestman, S., Dvir, A., Shaish, A., Ravid, M., and Harats, D. (2003). Low-dose interferon-alpha accelerates atherosclerosis in an LDL receptor-deficientmousemodel.Eur.J.Intern. Med. 14, 479-483.
70. Li, J., Fu, Q., Cui, H., Qu, B., Pan, W., Shen, N., and Bao, C. (2011). Interferon-alpha priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-alpha and atherosclerosis in lupus. Arthritis Rheum. 63, 492-502.
71. Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868-874.
72. Lopez-Pedrera, C., Aguirre, M. A., Bar-barroja, N., and Cuadrado, M. J. (2010). Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches. J. Bio-med. Biotechnol. 2010.
73. Lovgren, T., Eloranta, M. L., Bave, U., Alm, G.V., and Ronnblom, L. (2004). Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50, 1861-1872.
74. Maganto-Garcia, E., Tarrio, M. L., Gra-bie, N., Bu, D. X., and Lichtman, A. H. (2011). Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 124, 185-195.
75. Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C.,Staels, B., Duverger, N., Scherman, D., and Tedgui, A. (1999). Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85, e17- e24.
76. Manthey, H. D., and Zernecke, A. (2011). Dendritic cells in atherosclerosis: functions in immune regulation and beyond. Thromb. Haemost. 106, 772-778.
77. McClain, M. T., Heinlen, L. D., Dennis, G. J., Roebuck, J., Harley, J. B., and James, J. A. (2005). Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11, 85-89.
78. Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., and Luster, A. D. (2005). Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407-417.
79. Miloud, T., Hammerling, G. J., and Garbi, N. (2010). Review of murine dendritic cells: types, location, and development. Methods Mol. Biol. 595, 21-42.
80. Moore, K. J., and Tabas, I. (2011). Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355.
81. Naik, S. H. (2008). Demystifying the development of dendritic cell subtypes, a little. Immunol. Cell Biol. 86, 439-452.
82. Nakajima, K., Yamashita, T., Kita, T., Takeda, M., Sasaki, N., Kasa-hara, K., Shinohara, M., Riki-take, Y., Ishida, T., Yokoyama, M., and Hirata, K. (2011). Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice. Arte-rioscler. Thromb. Vasc. Biol. 31, 1963-1972.
83. Nickel, T., Schmauss, D., Hanssen, H., Sicic, Z., Krebs, B., Jankl, S., Summo, C., Fraunberger, P., Walli, A. K., Pfeiler, S., and Weis, M. (2009). oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis 205, 442-450.
84. Niessner, A., Sato, K., Chaikof, E. L., Colmegna, I., Goronzy, J. J., and Weyand, C. M. (2006). Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation 114, 2482-2489.
85. Niessner, A., Shin, M. S., Pryshchep, O., Goronzy, J. J., Chaikof, E. L., and Weyand, C. M. (2007). Syner-gistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 116, 2043-2052.
86. Niessner, A., and Weyand, C. M. (2010). Dendritic cells in atherosclerotic disease. Clin. Immunol. 134, 25-32.
87. Noels, H., and Weber, C. (2011). Catch-ingupwith important playersinath-erosclerosis: type I interferons and neutrophils. Curr. Opin. Lipidol. 22, 144-145.
88. Ochando, J. C., Homma, C., Yang, Y., Hidalgo, A., Garin, A., Tacke, F., Angeli, V., Li, Y., Boros, P., Ding, Y., Jessberger, R., Trinchieri, G., Lira, S. A., Randolph, G. J., and Bromberg, J. S. (2006). Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7, 652-662.
89. Perrins, C. J., and Bobryshev, Y. V. (2011). Current advances in understanding of immunopathology of atherosclerosis. Virchows Arch. 458, 117-123.
90. Pertovaara, M., Kahonen, M., Juonala, M., Laitinen, T., Taittonen, L., Lehti-maki, T., Viikari, J. S., Raitakari, O. T., and Hurme, M. (2009). Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The Cardiovascular Risk in Young Finns Study. Rheumatology 48, 1553-1556.
91. Pestka, S., Langer, J. A., Zoon, K. C., and Samuel, C. E. (1987). Interfer-ons and their actions. Annu. Rev. Biochem. 56, 727-777.
92. Puccetti, P., and Grohmann, U. (2007). IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat. Rev. Immunol. 7, 817-823.
93. Puddu, P., Puddu, G. M., Cravero, E., Muscari, S., and Muscari, A. (2010). The functional role of dendritic cells in atherogenesis (review). Mol. Med. Reports 3, 551-554.
94. Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L., and Sisirak, V. (2011a). Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163-183.
95. Reizis, B., Colonna, M., Trinchieri, G., Barrat, F., and Gilliet, M. (2011b). Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat. Rev. Immunol. 11, 558-565.
96. Ronnblom, L. (2011). The type I inter-feron system in the etiopathogene-sis of autoimmune diseases. Ups. J. Med. Sci. 116, 227-237.
97. Ronnblom, L., Eloranta, M. L., and Alm, G. V. (2003). Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36, 463-472.
98. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
99. Rupprecht,H.J., Blankenberg,S., Bickel, C., Rippin, G., Hafner, G., Prellwitz, W., Schlumberger, W., and Meyer, J. (2001). Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104, 25-31.
100. Sandgren, S., Wittrup, A., Cheng, F., Jonsson, M., Eklund, E., Busch, S., and Belting, M. (2004). The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocyto-sis. J. Biol. Chem. 279, 17951-17956.
101. Sherer, Y., Zinger, H., and Shoenfeld, Y. (2010). Atherosclerosis in systemic lupuserythematosus.Autoimmunity 43, 98-102.
102. Shi, H., Ge, J., Fang, W., Yao, K., Sun, A., Huang, R., Jia, Q., Wang, K., Zou, Y., and Cao, X. (2007). Peripheral-blood dendritic cells in men with coronary heart disease. Am. J. Car-diol. 100, 593-597.
103. Shortman, K., and Naik, S. H. (2007). Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30.
104. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., and Liu, Y. J. (1999). The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837.
105. Sorrentino, R., Morello, S., and Pinto, A. (2010). Plasmacytoid dendritic cells: from heart to vessels. Int. J. Vasc. Med. 2010, 430318.
106. Stemme,S.,Faber,B.,Holm,J.,Wiklund, O., Witztum, J. L., and Hansson, G. K. (1995). T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipopro-tein. Proc. Natl. Acad. Sci. U.S.A. 92, 3893-3897.
107. Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y., and Colonna, M. (2010). Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33, 955-966.
108. Swirski, F. K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., and Pittet, M. J. (2007). Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195-205.
109. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llo-dra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., Lira, S. A., Habenicht, A. J., and Randolph, G. J. (2007). Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Investig. 117, 185-194.
110. Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Perez, N., Yasukawa, H., van Snick, J., Yoshimura, A., Tedgui, A., and Mallat, Z. (2009). Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 206, 2067-2077.
111. Tew, J. G., El Shikh, M. E., El Sayed, R. M., and Schenkein, H. A. (2012). Dendritic cells, antibodies reactive with oxLDL, and inflammation. J. Dent. Res. 91, 8-16.
112. Thacker, S. G., Berthier, C. C., Mat-tinzoli, D., Rastaldi, M. P., Kretzler, M., and Kaplan, M. J. (2010). The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogene-sis and renal vascular rarefaction. J. Immunol. 185, 4457-4469.
113. van Brussel, I., van Vre, E. A., De Meyer, G. R., Vrints, C. J., Bosmans, J. M., and Bult, H. (2010). Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood. J. Immunol. Methods 362, 168-175.
114. van Brussel, I., van Vre, E. A., De Meyer, G. R., Vrints, C. J., Bosmans, J. M., and Bult, H. (2011). Decreasednum-bers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function. Clin. Sci. 120, 415-426.
115. van Es, T., van Puijvelde, G. H., Ramos, O. H., Segers, F. M., Joosten, L. A., van Den Berg, W. B., Michon, I. M., De Vos, P., van Berkel, T. J., and Kuiper, J. (2009). Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem. Biophys. Res. Commun. 388, 261-265.
116. van Vre, E. A., Hoymans, V. Y., Bult, H., Lenjou, M., van Bockstaele, D. R., Vrints, C. J., and Bosmans, J. M. (2006). Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coron. Artery Dis. 17, 243-248.
117. Weber, C., Meiler, S., Doring, Y., Koch, M., Drechsler, M., Megens, R. T., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., van Zandvoort, M. A., Binder, C. J., Jelinek, I., Hris-tov, M., Boon, L., Jung, S., Korn, T., Lutz, M. B., Forster, I., Zenke, M., Hieronymus, T., Junt, T., and Zernecke, A. (2011). CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 121, 2898-2910.
118. Weber, C., and Noels, H. (2011). Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410-1422.
119. Weber, C., Zernecke, A., and Libby, P. (2008). The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8, 802-815.
120. Wen, J., Wen, Y., Zhiliang, L., Lin-gling, C., Longxing, C., Ming, W., and Qiang, F. (2012). A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions? Heart Vessels. [Epub ahead of print].
121. Wigren, M., Kolbus, D., Duner, P., Ljungcrantz, I., Soderberg, I., Bjork-backa, H., Fredrikson, G. N., and Nilsson, J. (2011). Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J. Intern. Med. 269, 546-556.
122. Yilmaz, A., Lochno, M., Traeg, F., Cicha, I., Reiss, C., Stumpf, C., Raaz, D., Anger,T.,Amann,K.,Probst,T.,Lud-wig, J., Daniel, W. G., and Garlichs, C.D.(2004).Emergenceofdendritic cellsin rupture-prone regionsof vulnerable carotid plaques. Atherosclerosis 176, 101-110.
123. Yilmaz, A., Rowley, A., Schulte, D. J., Doherty, T. M., Schroder, N. W., Fishbein, M. C., Kalelkar, M., Cicha, I., Schubert, K., Daniel, W. G., Garlichs, C. D., and Arditi, M. (2007). Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease. Exp. Mol. Pathol. 83, 93-103.
124. Yilmaz, A., Schaller, T., Cicha, I., Altendorf,R.,Stumpf,C.,Klingham-mer, L., Ludwig, J., Daniel,W. G., and Garlichs, C. D. (2009). Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease. Clin. Sci. 116, 353-363.
125. Zernecke, A., Bot, I., Djalali-Talab, Y., Shagdarsuren, E., Bidzhekov, K., Meiler, S., Krohn, R., Schober, A., Sperandio,M.,Soehnlein,O.,Borne-mann, J., Tacke, F., Biessen, E. A., and Weber, C. (2008). Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neu-trophils in atherosclerosis. Circ. Res. 102, 209-217.
126. Zhu, S. N., Chen, M., Jongstra-Bilen, J., and Cybulsky, M.I. (2009). GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 206, 2141-2149.